Treatment of myelodysplastic syndromes.
Chng
Wee J
WJ
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D000077269:Lenalidomide; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage* / Q000031:analogs & derivatives*
D020533:Angiogenesis Inhibitors; D013792:Thalidomide; D000077269:Lenalidomide